The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-2-Amino-2-cyclohexyl-N-(3-methoxy-4-(oxazol-5-yl)phenyl)acetamide ID: ALA4874269
PubChem CID: 164628442
Max Phase: Preclinical
Molecular Formula: C18H23N3O3
Molecular Weight: 329.40
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc(NC(=O)[C@H](N)C2CCCCC2)ccc1-c1cnco1
Standard InChI: InChI=1S/C18H23N3O3/c1-23-15-9-13(7-8-14(15)16-10-20-11-24-16)21-18(22)17(19)12-5-3-2-4-6-12/h7-12,17H,2-6,19H2,1H3,(H,21,22)/t17-/m1/s1
Standard InChI Key: FMSWTTBYAYHETJ-QGZVFWFLSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
23.3793 -26.8146 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3782 -27.6341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0862 -28.0431 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7959 -27.6336 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7931 -26.8110 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0844 -26.4057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6715 -26.4069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.5859 -25.5942 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.7865 -25.4245 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3780 -26.1324 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.9250 -26.7394 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6702 -28.0421 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.9628 -27.6330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5042 -28.0411 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.2113 -27.6314 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9197 -28.0389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2100 -26.8142 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.6267 -27.6292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9209 -28.8561 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.3317 -28.0410 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0367 -27.6348 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0396 -26.8173 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3314 -26.4076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.6203 -26.8155 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 1 0
8 9 1 0
9 10 2 0
10 11 1 0
11 7 2 0
1 7 1 0
2 12 1 0
12 13 1 0
4 14 1 0
14 15 1 0
15 16 1 0
15 17 2 0
16 18 1 0
16 19 1 1
18 20 1 0
18 24 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 329.40Molecular Weight (Monoisotopic): 329.1739AlogP: 3.20#Rotatable Bonds: 5Polar Surface Area: 90.38Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.74CX Basic pKa: 8.34CX LogP: 1.96CX LogD: 0.98Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.88Np Likeness Score: -0.57
References 1. Hartz RA, Ahuja VT, Nara SJ, Kumar CMV, Brown JM, Bristow LJ, Rajamani R, Muckelbauer JK, Camac D, Kiefer SE, Hunihan L, Gulianello M, Lewis M, Easton A, Lippy JS, Surti N, Pattipati SN, Dokania M, Elavazhagan S, Dandapani K, Hamman BD, Allen J, Kostich W, Bronson JJ, Macor JE, Dzierba CD.. (2021) Discovery, Structure-Activity Relationships, and In Vivo Evaluation of Novel Aryl Amides as Brain Penetrant Adaptor Protein 2-Associated Kinase 1 (AAK1) Inhibitors for the Treatment of Neuropathic Pain., 64 (15.0): [PMID:34270254 ] [10.1021/acs.jmedchem.1c00472 ]